{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:17:39Z","timestamp":1789683459388,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.kint.2020.06.045","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:00:09Z","timestamp":1596308409000},"page":"1449-1460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome"],"prefix":"10.1016","volume":"98","author":[{"given":"Eduardo","family":"Molina-Jijon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Gambut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Mac\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Avila-Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel C.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.06.045_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","article-title":"New insights into human minimal change disease: lessons from animal models","volume":"59","author":"Chugh","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.06.045_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2020.06.045_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1139\/o67-133","article-title":"Isolation, purification, and characterization of gamma-lipotropic hormone from sheep pituitary glands","volume":"45","author":"Chr\u00e9tien","year":"1967","journal-title":"Can J Biochem"},{"key":"10.1016\/j.kint.2020.06.045_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1126\/science.157.3789.697","article-title":"Insulin biosynthesis: evidence for a precursor","volume":"157","author":"Steiner","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.kint.2020.06.045_bib5","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2020.06.045_bib6","doi-asserted-by":"crossref","first-page":"48865","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"Benjannet","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2020.06.045_bib7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biocel.2008.01.030","article-title":"The activation and physiological functions of the proprotein convertases","volume":"40","author":"Seidah","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.kint.2020.06.045_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nsmb1235","article-title":"Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia","volume":"14","author":"Cunnigham","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.kint.2020.06.045_bib9","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1074\/jbc.M110.192104","article-title":"In\u00a0vivo evidence that furin from hepatocytes inactivates PCSK9","volume":"286","author":"Essalmani","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2020.06.045_bib10","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.1074\/jbc.M606495200","article-title":"The proprotein convertase (PC) PCSK9 is inactivated by furin and\/or PC5\/6A: functional consequences of natural mutations and post-translational modifications","volume":"281","author":"Benjannet","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2020.06.045_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1194\/jlr.M049346","article-title":"Isolation and characterization of the circulating truncated form of PCSK9","volume":"55","author":"Han","year":"2014","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2020.06.045_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause\u00a0autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2020.06.045_bib13","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation","volume":"282","author":"Zhang","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2020.06.045_bib14","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2020.06.045_bib15","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2020.06.045_bib16","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1194\/jlr.M700071-JLR200","article-title":"Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis","volume":"48","author":"Qian","year":"2007","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2020.06.045_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000365935","article-title":"Elevated circulating PCSK-9 concentration in renal failure patients is corrected by renal replacement therapy","volume":"40","author":"Konarzewski","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2020.06.045_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00467-004-1696-5","article-title":"Rapid development of glomerular injury and renal failure in mice lacking p53R2","volume":"20","author":"Powell","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2020.06.045_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI0212858","article-title":"Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo\/Mna rats","volume":"109","author":"Le Berre","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2020.06.045_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000183718","article-title":"Sclerotic lesions in the glomeruli of Buffalo\/Mna rats","volume":"43","author":"Nakamura","year":"1986","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2020.06.045_bib21","doi-asserted-by":"crossref","first-page":"39681","DOI":"10.1074\/jbc.M606664200","article-title":"ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome","volume":"281","author":"Liu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2020.06.045_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2020.06.045_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1523-1755.2001.059002601.x","article-title":"Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum","volume":"59","author":"Chugh","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.06.045_bib24","doi-asserted-by":"crossref","first-page":"19266","DOI":"10.1074\/jbc.M112.363382","article-title":"Regulation of epithelial sodium channel trafficking by proprotein convertase subtilisin\/kexin type 9 (PCSK9)","volume":"287","author":"Sharotri","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2020.06.045_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.115.020912","article-title":"The role of proprotein convertase subtilisin\/kexin type 9 in nephrotic syndrome-associated hypercholesterolemia","volume":"134","author":"Haas","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2020.06.045_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ndt\/gft439","article-title":"Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome","volume":"29","author":"Liu","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2020.06.045_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2019.11.011","article-title":"The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseases","volume":"97","author":"Mac\u00e9","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.06.045_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/j.ajkd.2013.10.042","article-title":"Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study","volume":"63","author":"Jin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.06.045_bib29","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/ki.1995.500","article-title":"Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis","volume":"48","author":"Vaziri","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.06.045_bib30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000082510","article-title":"Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome","volume":"24","author":"Vaziri","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2020.06.045_bib31","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1093\/ndt\/gfr136","article-title":"Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor","volume":"26","author":"Vaziri","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2020.06.045_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1523-1755.1999.00585.x","article-title":"Down-regulation of hepatic high-density lipoprotein\u00a0receptor, SR-B1, in nephrotic syndrome","volume":"56","author":"Liang","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.06.045_bib33","doi-asserted-by":"crossref","first-page":"F823","DOI":"10.1152\/ajprenal.2001.280.5.F823","article-title":"Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome","volume":"280","author":"Vaziri","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2020.06.045_bib34","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1046\/j.1523-1755.2002.00319.x","article-title":"Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome","volume":"61","author":"Vaziri","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.06.045_bib35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/01.CIR.0000136023.70841.0F","article-title":"Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-density lipoprotein receptor deficiencies in nephrotic syndrome","volume":"110","author":"Vaziri","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2020.06.045_bib36","doi-asserted-by":"crossref","first-page":"E813","DOI":"10.1152\/ajpendo.00266.2004","article-title":"Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy","volume":"288","author":"Kim","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.kint.2020.06.045_bib37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1159\/000193631","article-title":"Sterol regulatory element-binding proteins, liver X receptor, ABCA1 transporter, CD36, scavenger receptors A1 and B1 in nephrotic kidney","volume":"29","author":"Kim","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2020.06.045_bib38","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.metabol.2007.05.007","article-title":"Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome","volume":"56","author":"Kim","year":"2007","journal-title":"Metabolism"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382030898X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382030898X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:56:58Z","timestamp":1758761818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525382030898X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S008525382030898X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.06.045","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.06.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}